Fiche publication


Date publication

janvier 2017

Journal

Clinical nuclear medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOULAHDOUR Hatem


Tous les auteurs :
Drouet C, Morel O, Boulahdour H

Résumé

FDG PET/CT has high sensitivity and specificity for the detection of distant metastases from cutaneous melanoma. Imaging is recommended for patients with clinical suspicion of metastasis and should be considered for those with confirmed sentinel lymph node metastasis. Metastatic melanoma bears a poor prognosis. Only a complete resection improves survival, which explains the need to detect potentially unresectable disease, and most metastatic patients are ineligible for a curative surgical procedure. Here, FDG PET/CT demonstrated isolated bilateral adrenal metastases from melanoma of unknown primary. The patient underwent curative surgery, with no sign of recurrence at 48 months after surgery.

Mots clés

Adrenal Gland Neoplasms, diagnostic imaging, Fluorodeoxyglucose F18, Humans, Incidental Findings, Male, Melanoma, diagnostic imaging, Middle Aged, Neoplasms, Unknown Primary, diagnostic imaging, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals

Référence

Clin Nucl Med. 2017 01;42(1):e51-e53